DARIOHEALTH CORP (DRIO)
US23725P2092 - Common Stock
Taking everything into account, DRIO scores 2 out of 10 in our fundamental rating. DRIO was compared to 40 industry peers in the Health Care Technology industry. DRIO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DRIO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year DRIO has reported negative net income.
DRIO had a negative operating cash flow in the past year.
In the past 5 years DRIO always reported negative net income.
In the past 5 years DRIO always reported negative operating cash flow.
1.2 Ratios
DRIO's Return On Assets of -65.90% is on the low side compared to the rest of the industry. DRIO is outperformed by 66.67% of its industry peers.
DRIO's Return On Equity of -109.24% is on the low side compared to the rest of the industry. DRIO is outperformed by 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.9% | ||
| ROE | -109.24% | ||
| ROIC | N/A |
ROA(3y)-65.86%
ROA(5y)-75.2%
ROE(3y)-93.72%
ROE(5y)-101.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRIO has a Gross Margin of 29.39%. This is amonst the worse of the industry: DRIO underperforms 82.05% of its industry peers.
In the last couple of years the Gross Margin of DRIO has grown nicely.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.88%
GM growth 5Y4.19%
2. Health
2.1 Basic Checks
DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
DRIO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRIO has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -5.67, we must say that DRIO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DRIO (-5.67) is worse than 76.92% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that DRIO is not too dependend on debt financing.
The Debt to Equity ratio of DRIO (0.42) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.67 |
ROIC/WACCN/A
WACC12.33%
2.3 Liquidity
A Current Ratio of 3.79 indicates that DRIO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.79, DRIO is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
DRIO has a Quick Ratio of 3.38. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
DRIO's Quick ratio of 3.38 is fine compared to the rest of the industry. DRIO outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.38 |
3. Growth
3.1 Past
DRIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.19%, which is quite impressive.
Looking at the last year, DRIO shows a very negative growth in Revenue. The Revenue has decreased by -26.41% in the last year.
The Revenue has been growing by 22.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.19%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q1.96%
Revenue 1Y (TTM)-26.41%
Revenue growth 3Y38.99%
Revenue growth 5Y22.46%
Revenue growth Q2Q-46.9%
3.2 Future
DRIO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.72% yearly.
Based on estimates for the next years, DRIO will show a very strong growth in Revenue. The Revenue will grow by 51.97% on average per year.
EPS Next Y-2%
EPS Next 2Y13.38%
EPS Next 3Y17.72%
EPS Next 5YN/A
Revenue Next Year83.18%
Revenue Next 2Y56.44%
Revenue Next 3Y53.65%
Revenue Next 5Y51.97%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for DRIO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRIO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
DRIO's earnings are expected to grow with 17.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.38%
EPS Next 3Y17.72%
5. Dividend
5.1 Amount
DRIO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DARIOHEALTH CORP
NASDAQ:DRIO (4/26/2024, 7:00:02 PM)
1.48
+0.01 (+0.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap43.57M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -65.9% | ||
| ROE | -109.24% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 29.39% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)23.19%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-26.41%
Revenue growth 3Y38.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y